Table 3.
WHO ATC/DDD index | Number of drugs | |
---|---|---|
PMACS | No PMACS | |
Antineoplastic and immunomodulating agents | 6 | 2 |
Anti-infectives for systemic use | 2 | 9 |
Nervous system | 1 | 5 |
Musculo-skeletal system | 1 | 1 |
Alimentary tract metabolism | 0 | 1 |
Blood and blood forming organs | 0 | 1 |
Cardiovascular system | 0 | 1 |
Among drugs with reexamination reports issued from 2017 to 2019, those with five or more PI change orders during their reexamination period were accumulated, categorized by WHO ATC/DDD index and compared based on mandatory status of PMAC.
PMACS, postmarketing all-case surveillance; WHO ATC/DDD, World Health Organization anatomical therapeutic chemical and defined daily dose.